Absorption and Excretion of Cholesterol and Other Sterols

Clinical Lipidology: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2009, Pages 26-44

  Wang, David Q H ^a   Cohen, David E ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882510579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141605469-6.50007-X     Document Type: Chapter

References (197)

1. Wang DQ-H Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007, 69:221-248.
2. The National Cholesterol Education Program Expert Panel Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
3. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004, 44:720-732.
4. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113:2363-2372.
5. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
6. Hofmann AF Bile acids. The Liver: Biology and Pathobiology 1994, 677-718. Raven Press, New York. 3rd. I.M. Arias, J.L. Boyer, N. Fausto (Eds.).
7. Heuman DM Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989, 30:719-730.
8. Carey MC, Duane WC Enterohepatic circulation. The Liver: Biology and Pathobiology 1994, 719-767. Raven Press, New York. 3rd. I.M. Arias, J.L. Boyer, N. Fausto (Eds.).
9. Kirby RJ, Zheng S, Tso P, et al. Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via ceramide hydrolysis. J Biol Chem 2002, 277:4104-4109.
10. Weng W, Li L, van Bennekum AM, et al. Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice. Biochemistry 1999, 38:4143-4149.
11. Huggins KW, Camarota LM, Howles PN, et al. Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J Biol Chem 2003, 278:42899-42905.
12. Roberts IM, Montgomery RK, Carey MC Rat lingual lipase: partial purification, hydrolytic properties, and comparison with pancreatic lipase. Am J Physiol 1984, 247:G385-G393.
13. Field RB, Scow RO Purification and characterization of rat lingual lipase. J Biol Chem 1983, 258:14563-14569.
14. Liao TH, Hamosh P, Hamosh M Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr Res 1984, 18:402-409.
15. Regan PT, Malagelada JR, Dimagno EP, et al. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology 1979, 77:285-289.
16. Bouquet J, Sinaasappel M, Neijens HJ Malabsorption in cystic fibrosis: mechanisms and treatment. J Pediatr Gastroenterol Nutr 1988, 7(Suppl 1):S30-S35.
17. Borgstrom B On the action of pancreatic lipase on triglycerides in vivo and in vitro. Acta Physiol Scand 1952, 25:328-347.
18. Borgstrom B On the mechanism of pancreatic lipolysis of glycerides. Biochim Biophys Acta 1954, 13:491-504.
19. Mattson FH, Volpenhein RA Hydrolysis of primary and secondary esters of glycerol by pancreatic juice. J Lipid Res 1968, 9:79-84.
20. Mattson FH, Volpenhein RA The digestion and absorption of triglycerides. J Biol Chem 1964, 239:2772-2777.
21. Patton JS, Carey MC Watching fat digestion. Science 1979, 204:145-148.
22. Borgstrom B, Erlanson C Pancreatic juice co-lipase: physiological importance. Biochim Biophys Acta 1971, 242:509-513.
23. Erlanson C, Borgstrom B Purification and further characterization of co-lipase from porcine pancreas. Biochim Biophys Acta 1972, 271:400-412.
24. Baskys B, Klein E, Lever WF Lipases of blood and tissues. iii. Purification and properties of pancreatic lipase. Arch Biochem Biophys 1963, 102:201-209.
25. Morgan RG, Barrowman J, Borgstrom B The effect of sodium taurodesoxycholate and pH on the gel filtration behavior of rat pancreatic protein and lipases. Biochim Biophys Acta 1969, 175:65-75.
26. Borgstrom B On the interactions between pancreatic lipase and colipase and the substrate, and the importance of bile salts. J Lipid Res 1975, 16:411-417.
27. Lombardo D, Fauvel J, Guy O Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta 1980, 611:136-146.
28. Lombardo D, Guy O Binding of human pancreatic carboxylic ester hydrolase to lipid interfaces. Biochim Biophys Acta 1981, 659:401-410.
29. Blackberg L, Lombardo D, Hernell O, et al. Bile salt-stimulated lipase in human milk and carboxyl ester hydrolase in pancreatic juice: are they identical enzymes?. FEBS Lett 1981, 136:284-288.
30. Hofmann AF, Borgstrom B Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc 1962, 21:43-50.
31. Staggers JE, Hernell O, Stafford RJ, et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 1990, 29:2028-2040.
32. Hernell O, Staggers JE, Carey MC Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 1990, 29:2041-2056.
33. 14-Cholesterol. V. Obligatory function of bile in intestinal absorption of cholesterol. J Biol Chem 1952, 198:111-114.
34. Hofmann AF, Small DM Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 1967, 18:333-376.
35. Simmonds WJ, Hofmann AF, Theodor E Absorption of cholesterol from a micellar solution: intestinal perfusion studies in man. J Clin Invest 1967, 46:874-890.
36. Borgstrom B The micellar hypothesis of fat absorption: must it be revisited?. Scand J Gastroenterol 1985, 20:389-394.
37. Westergaard H, Dietschy JM The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J Clin Invest 1976, 58:97-108.
38. Wilson FA, Sallee VL, Dietschy JM Unstirred water layers in intestine: rate determinant of fatty acid absorption from micellar solutions. Science 1971, 174:1031-1033.
39. Wang DQ-H, Tazuma S, Cohen DE, et al. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am J Physiol Gastrointest Liver Physiol 2003, 285:G494-G502.
40. Wang DQ-H, Lammert F, Cohen DE, et al. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am J Physiol 1999, 276:G751-G760.
41. -/- mice. Am J Physiol Gastrointest Liver Physiol 2004, 287:G547-G554.
42. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
43. Lee MH, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001, 27:79-83.
44. Bhattacharyya AK, Connor WE β-Sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974, 53:1033-1043.
45. Miettinen TA Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 1980, 10:27-35.
46. Salen G, Shore V, Tint GS, et al. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res 1989, 30:1319-1330.
47. Salen G, Tint GS, Shefer S, et al. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler Thromb 1992, 12:563-568.
48. Yu L, Li-Hawkins J, Hammer RE, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002, 110:671-680.
49. Yu L, Hammer RE, Li-Hawkins J, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 2002, 99:16237-16242.
50. Wang HH, Patel SB, Carey MC, et al. Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology 2007, 45:998-1006.
51. Duan LP, Wang HH, Wang DQ-H Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J Lipid Res 2004, 45:1312-1323.
52. Berge KE, von Bergmann K, Lutjohann D, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002, 43:486-494.
53. Maki KC, Davidson MH, Umporowicz DM, et al. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 2001, 74:33-43.
54. Miettinen TA, Puska P, Gylling H, et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995, 333:1308-1312.
55. Ostlund RE, Racette SB, Okeke A, et al. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr 2002, 75:1000-1004.
56. Nissinen M, Gylling H, Vuoristo M, et al. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. Am J Physiol Gastrointest Liver Physiol 2002, 282:G1009-G1015.
57. Ikeda I, Tanabe Y, Sugano M Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J Nutr Sci Vitaminol (Tokyo) 1989, 35:361-369.
58. Ikeda I, Tanaka K, Sugano M, et al. Discrimination between cholesterol and sitosterol for absorption in rats. J Lipid Res 1988, 29:1583-1591.
59. Ikeda I, Tanaka K, Sugano M, et al. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res 1988, 29:1573-1582.
60. Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J Biol Chem 2002, 277:18793-18800.
61. van Heek M, Farley C, Compton DS, et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 2000, 129:1748-1754.
62. Altmann SW, Davis HR, Zhu LJ, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004, 303:1201-1204.
63. Davis HR, Zhu LJ, Hoos LM, et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 2004, 279:33586-33592.
64. Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 1997, 277:228-231.
65. Davies JP, Levy B, Ioannou YA Evidence for a Niemann-Pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics 2000, 65:137-145.
66. Iyer SP, Yao X, Crona JH, et al. Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochim Biophys Acta 2005, 1722:282-292.
67. Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005, 102:8132-8137.
68. Smart EJ, De Rose RA, Farber SA Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc Natl Acad Sci USA 2004, 101:3450-3455.
69. Repa JJ, Dietschy JM, Turley SD Inhibition of cholesterol absorption by SCH 5805. in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte. J Lipid Res 2002, 43:1864-1874.
70. van Heek M, Farley C, Compton DS, et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 2001, 134:409-417.
71. Sparrow CP, Patel S, Baffic J, et al. A fluorescent cholesterol analog traces cholesterol absorption in hamsters and is esterified in vivo and in vitro. J Lipid Res 1999, 40:1747-1757.
72. Hernandez M, Montenegro J, Steiner M, et al. Intestinal absorption of cholesterol is mediated by a saturable, inhibitable transporter. Biochim Biophys Acta 2000, 1486:232-242.
73. Detmers PA, Patel S, Hernandez M, et al. A target for cholesterol absorption inhibitors in the enterocyte brush border membrane. Biochim Biophys Acta 2000, 1486:243-252.
74. Kramer W, Glombik H, Petry S, et al. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter. FEBS Lett 2000, 487:293-297.
75. Kramer W, Girbig F, Corsiero D, et al. Intestinal cholesterol absorption: identification of different binding proteins for cholesterol and cholesterol absorption inhibitors in the enterocyte brush border membrane. Biochim Biophys Acta 2003, 1633:13-26.
76. Kramer W, Girbig F, Corsiero D, et al. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J Biol Chem 2005, 280:1306-1320.
77. Orso E, Werner T, Wolf Z, et al. Ezetimib influences the expression of raft-associated antigens in human monocytes. Cytometry A 2006, 69:206-208.
78. Hauser H, Dyer JH, Nandy A, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998, 37:17843-17850.
79. Cai SF, Kirby RJ, Howles PN, et al. Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine. J Lipid Res 2001, 42:902-909.
80. Altmann SW, Davis HR, Yao X, et al. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 2002, 1580:77-93.
81. Mardones P, Quinones V, Amigo L, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001, 42:170-180.
82. Wang DQ-H, Carey MC Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI. Biochim Biophys Acta 2002, 1583:141-150.
83. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000, 289:1524-1529.
84. McNeish J, Aiello RJ, Guyot D, et al. High-density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 2000, 97:4245-4250.
85. Drobnik W, Lindenthal B, Lieser B, et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 2001, 120:1203-1211.
86. Plosch T, Kok T, Bloks VW, et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 2002, 277:33870-33877.
87. Attie AD, Hamon Y, Brooks-Wilson AR, et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. J Lipid Res 2002, 43:1610-1617.
88. Mulligan JD, Flowers MT, Tebon A, et al. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem 2003, 278:13356-13366.
89. Lawn RM, Wade DP, Couse TL, et al. Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues. Arterioscler Thromb Vasc Biol 2001, 21:378-385.
90. Lee RG, Willingham MC, Davis MA, et al. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res 2000, 41:1991-2001.
91. Abumrad N, Harmon C, Ibrahimi A Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 1998, 39:2309-2318.
92. Stahl A, Hirsch DJ, Gimeno RE, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 1999, 4:299-308.
93. Poirier H, Degrace P, Niot I, et al. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem 1996, 238:368-373.
94. van Greevenbroek MM, Robertus-Teunissen MG, Erkelens DW, et al. Participation of the microsomal triglyceride transfer protein in lipoprotein assembly in Caco-2 cells: interaction with saturated and unsaturated dietary fatty acids. J Lipid Res 1998, 39:173-185.
95. Heider JG, Pickens CE, Kelly LA Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J Lipid Res 1983, 24:1127-1134.
96. Clark SB, Tercyak AM Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J Lipid Res 1984, 25:148-159.
97. Buhman KK, Accad M, Novak S, et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 2000, 6:1341-1347.
98. Hajri T, Ferezou J, Laruelle C, et al. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats. Eur J Pharmacol 1995, 286:131-136.
99. Nielsen LB, Stender S, Kjeldsen K Effect of lovastatin on cholesterol absorption in cholesterol-fed rabbits. Pharmacol Toxicol 1993, 72:148-151.
100. Vanhanen H, Kesaniemi YA, Miettinen TA Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 1992, 41:588-595.
101. Manganaro F, Kuksis A Purification and preliminary characterization of 2-monoacylglycerol acyltransferase from rat intestinal villus cells. Can J Biochem Cell Biol 1985, 63:341-347.
102. Rao GA, Johnston JM Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim Biophys Acta 1966, 125:465-473.
103. Bell RM, Ballas LM, Coleman RA Lipid topogenesis. J Lipid Res 1981, 22:391-403.
104. Polheim D, David JS, Schultz FM, et al. Regulation of triglyceride biosynthesis in adipose and intestinal tissue. J Lipid Res 1973, 14:415-421.
105. Miller KW, Small DM Surface-to-core and interparticle equilibrium distributions of triglyceride-rich lipoprotein lipids. J Biol Chem 1983, 258:13772-13784.
106. Miller KW, Small DM Triolein-cholesteryl oleate-cholesterol-lecithin emulsions: structural models of triglyceride-rich lipoproteins. Biochemistry 1983, 22:443-451.
107. Chen SH, Habib G, Yang CY, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987, 238:363-366.
108. Powell LM, Wallis SC, Pease RJ, et al. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 1987, 50:831-840.
109. Zilversmit DB The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965, 44:1610-1622.
110. Redgrave TG, Dunne KB Chylomicron formation and composition in unanaesthetised rabbits. Atherosclerosis 1975, 22:389-400.
111. Karmen A, Whyte M, Goodman DS Fatty acid esterification and chylomicron formation during fat absorption. 1. Triglycerides and cholesterol esters. J Lipid Res 1963, 4:312-321.
112. Whyte M, Karmen A, Goodman DS Fatty acid esterification and chylomicron formation during fat absorption. 2. Phospholipids. J Lipid Res 1963, 4:322-329.
113. Hussain MM A proposed model for the assembly of chylomicrons. Atherosclerosis 2000, 148:1-15.
114. Dashti N Synthesis and secretion of nascent lipoprotein particles. Prog Lipid Res 1991, 30:219-230.
115. Levy E, Mehran M, Seidman E Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 1995, 9:626-635.
116. Field FJ, Mathur SN Intestinal lipoprotein synthesis and secretion. Prog Lipid Res 1995, 34:185-198.
117. Green PH, Glickman RM Intestinal lipoprotein metabolism. J Lipid Res 1981, 22:1153-1173.
118. Hamilton RL, Wong JS, Cham CM, et al. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res 1998, 39:1543-1557.
119. Young SG, Cham CM, Pitas RE, et al. A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine. J Clin Invest 1995, 96:2932-2946.
120. Gordon DA, Jamil H, Gregg RE, et al. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step. J Biol Chem 1996, 271:33047-33053.
121. Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258:999-1001.
122. Ordovas JM, Schaefer EJ Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE gene. Br J Nutr 2000, 83(Suppl 1):S127-S136.
123. McNamara DJ, Kolb R, Parker TS, et al. Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest 1987, 79:1729-1739.
124. Kesaniemi YA, Miettinen TA Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 1987, 17:391-395.
125. Sehayek E, Nath C, Heinemann T, et al. U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res 1998, 39:2415-2422.
126. Miettinen TA, Tilvis RS, Kesaniemi YA Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131:20-31.
127. Bosner MS, Lange LG, Stenson WF, et al. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999, 40:302-308.
128. Wang DQ-H, Paigen B, Carey MC Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice. J Lipid Res 2001, 42:1820-1830.
129. Bhattacharyya AK, Eggen DA Cholesterol absorption and turnover in rhesus monkeys as measured by two methods. J Lipid Res 1980, 21:518-524.
130. Lofland HB, Clarkson TB, St Clair RW, et al. Studies on the regulation of plasma cholesterol levels in squirrel monkeys of two genotypes. J Lipid Res 1972, 13:39-47.
131. Kirk EA, Moe GL, Caldwell MT, et al. Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: searching for level and variability genes. J Lipid Res 1995, 36:1522-1532.
132. Carter CP, Howles PN, Hui DY Genetic variation in cholesterol absorption efficiency among inbred strains of mice. J Nutr 1997, 127:1344-1348.
133. Jolley CD, Dietschy JM, Turley SD Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness. Am J Physiol 1999, 276:G1117-G1124.
134. Schwarz M, Davis DL, Vick BR, et al. Genetic analysis of intestinal cholesterol absorption in inbred mice. J Lipid Res 2001, 42:1801-1811.
135. Beynen AC, Meijer GW, Lemmens AG, et al. Sterol balance and cholesterol absorption in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterol. Atherosclerosis 1989, 77:151-157.
136. Van Zutphen LF, Fox RR Strain differences in response to dietary cholesterol by JAX rabbits: correlation with esterase patterns. Atherosclerosis 1977, 28:435-446.
137. Van Zutphen LF, Den Bieman MG Cholesterol response in inbred strains of rats, Rattus norvegicus. J Nutr 1981, 111:1833-1838.
138. Gylling H, Miettinen TA Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J Lipid Res 2002, 43:1472-1476.
139. Wang DQ-H, Carey MC Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res 2003, 44:1042-1059.
140. Schwarz M, Russell DW, Dietschy JM, et al. Alternate pathways of bile acid synthesis in the cholesterol 7a-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J Lipid Res 2001, 42:1594-1603.
141. Repa JJ, Lund EG, Horton JD, et al. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J Biol Chem 2000, 275:39685-39692.
142. Akiyoshi T, Uchida K, Takase H, et al. Cholesterol gallstones in alloxan-diabetic mice. J Lipid Res 1986, 27:915-924.
143. Voshol PJ, Havinga R, Wolters H, et al. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice. Gastroenterology 1998, 114:1024-1034.
144. Dawson PA, Haywood J, Craddock AL, et al. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 2003, 278:33920-33927.
145. Wang DQ-H, Schmitz F, Kopin AS, et al. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 2004, 114:521-528.
146. Traber MG, Ostwald R Cholesterol absorption and steroid excretion in cholesterol-fed guinea pigs. J Lipid Res 1978, 19:448-456.
147. Ponz de Leon M, Iori R, Barbolini G, et al. Influence of small-bowel transit time on dietary cholesterol absorption in human beings. N Engl J Med 1982, 307:102-103.
148. Duan LP, Wang HH, Ohashi A, et al. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects. Am J Physiol Gastrointest Liver Physiol 2006, 290:G269-G276.
149. Turley SD, Schwarz M, Spady DK, et al. Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets. Hepatology 1998, 28:1088-1094.
150. Hollander D, Morgan D Increase in cholesterol intestinal absorption with aging in the rat. Exp Gerontol 1979, 14:201-204.
151. Wang DQ-H Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice. J Lipid Res 2002, 43:1950-1959.
152. Wang HH, Afdhal NH, Wang DQ-H Estrogen receptor a, but not b, plays a major role in 17b-estradiol-induced murine cholesterol gallstones. Gastroenterology 2004, 127:239-249.
153. Mittendorfer B, Ostlund RE, Patterson BW, et al. Orlistat inhibits dietary cholesterol absorption. Obes Res 2001, 9:599-604.
154. Muls E, Kolanowski J, Scheen A, et al. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Int J Obes Relat Metab Disord 2001, 25:1713-1721.
155. Insull W, Koren M, Davignon J, et al. Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis 2001, 157:137-144.
156. Heinemann T, Axtmann G, von Bergmann K Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993, 23:827-831.
157. Hallikainen MA, Sarkkinen ES, Gylling H, et al. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 2000, 54:715-725.
158. Sudhop T, von Bergmann K Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs 2002, 62:2333-2347.
159. Clader JW, Burnett DA, Caplen MA, et al. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. J Med Chem 1996, 39:3684-3693.
160. Van Heek M, France CF, Compton DS, et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997, 283:157-163.
161. Ezzet F, Krishna G, Wexler DB, et al. A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ther 2001, 23:871-885.
162. Melani L, Mills R, Hassman D, et al. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Eur Heart J 2003, 24:717-728.
163. Feldman T, Koren M, Insull W, et al. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals. Am J Cardiol 2004, 93:1481-1486.
164. Gagne C, Gaudet D, Bruckert E Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002, 105:2469-2475.
165. Knopp RH, Dujovne CA, Le Beaut A, et al. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies. Int J Clin Pract 2003, 57:363-368.
166. Dujovne CA, Bays H, Davidson MH, et al. Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study. J Clin Pharmacol 2001, 41:70-78.
167. Bays HE, Moore PB, Drehobl MA, et al. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 2001, 23:1209-1230.
168. Dujovne CA, Ettinger MP, McNeer JF, et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 2002, 90:1092-1097.
169. Salen G, von Bergmann K, Lutjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004, 109:966-971.
170. Tokyo Cooperative Gallstone Study Group: Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 1980, 78:542-548.
171. Makino I, Shinozaki K, Yoshino K, et al. Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid. Jpn J Gastroenterol 1975, 72:690-702.
172. Ponz de Leon M, Carulli N, Loria P, et al. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration. Gastroenterology 1980, 78:214-219.
173. Lanzini A, Northfield TC Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones. Gastroenterology 1988, 95:408-416.
174. Hardison WG, Grundy SM Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 1984, 87:130-135.
175. Leiss O, von Bergmann K, Streicher U, et al. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers. Gastroenterology 1984, 87:144-149.
176. Watt SM, Simmonds WJ Effects of four taurine-conjugated bile acids on mucosal uptake and lymphatic absorption of cholesterol in the rat. J Lipid Res 1984, 25:448-455.
177. Woollett LA, Buckley DD, Yao L, et al. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. J Lipid Res 2003, 44:935-942.
178. Johnson FL, St Clair RW, Rudel LL Effects of the degree of saturation of dietary fat on the hepatic production of lipoproteins in the African green monkey. J Lipid Res 1985, 26:403-417.
179. Chen IS, Hotta SS, Ikeda I, et al. Digestion, absorption and effects on cholesterol absorption of menhaden oil, fish oil concentrate and corn oil by rats. J Nutr 1987, 117:1676-1680.
180. Eckhardt ER, Wang DQ-H, Donovan JM, et al. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002, 122:948-956.
181. Vahouny GV, Roy T, Gallo LL, et al. Dietary fiber and lymphatic absorption of cholesterol in the rat. Am J Clin Nutr 1978, 31:S208-S210.
182. Huggins KW, Camarota LM, Howles PN, et al. Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J Biol Chem 2003, 278:42899-42905.
183. Bennett Clark S, Tercyak AM Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J Lipid Res 1984, 25:148-159.
184. Heider JG, Pickens CE, Kelly LA Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J Lipid Res 1983, 24:1127-1134.
185. Nielsen LB, Stender S, Kjeldsen K Effect of lovastatin on cholesterol absorption in cholesterol-fed rabbits. Pharmacol Toxicol 1993, 72:148-151.
186. Hajri T, Ferezou J, Laruelle C, et al. Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats. Eur J Pharmacol 1995, 286:131-136.
187. Vanhanen H, Kesaniemi YA, Miettinen TA Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 1992, 41:588-595.
188. Davidson MH, Dillon MA, Gordon B, et al. Colesevelam hydrochloride holestagel: a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999, 159:1893-1900.
189. Insull W, Toth P, Mullican W, et al. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Mayo Clin Proc 2001, 76:971-982.
190. Schwarz M, Russell DW, Dietschy JM, et al. Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res 1998, 39:1833-1843.
191. Valasek MA, Weng J, Shaul PW, et al. Caveolin-1 is not required for murine intestinal cholesterol transport. J Biol Chem 2005, 280:28103-28109.
192. Wang HH, Wang DQ-H Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology 2005, 42:894-904.
193. Weinstock PH, Bisgaier CL, Hayek T, et al. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. J Lipid Res 1997, 38:1782-1794.
194. Aalto-Setala K, Bisgaier CL, Ho A, et al. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Clin Invest 1994, 93:1776-1786.
195. Knight BL, Patel DD, Humphreys SM, et al. Inhibition of cholesterol absorption associated with a PPARα-dependent increase in ABC binding cassette transporter A1 in mice. J Lipid Res 2003, 44:2049-2058.
196. van der Veen JN, Kruit JK, Havinga R, et al. Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res 2005, 46:526-534.
197. Kirby RJ, Howles PN, Hui DY Rate of gastric emptying influences dietary cholesterol absorption efficiency in selected inbred strains of mice. J Lipid Res 2004, 45:89-98.